Comments corpgov has made
methodology
One flaw, among many, not mentioned in the article is the fact that the 10 companies studies by the academics were hand picked by the Chamber. Even if they weren't, ten is too few for a valid sample. However, having them picked by the Chamber is the height of absurdity. Would you have the drug companies pick patients out of thousands who took their medicine to represent them all? Of course not.On Study claims shareholder and climate activism are bad for stock prices posted 1 year, 3 months ago 7 Responses